| Name | Walgreens #4975 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 1542 Wayne Ave, Dayton, Ohio 45410 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (937) 254-2156 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Researchers with the National Cancer Institute (NCI) have found that the prevalence of tamoxifen use for the prevention of breast cancer among women without a personal history of breast cancer is very low.
Isis Pharmaceuticals, Inc. announced the initiation of two Phase 2 studies of ISIS-EIF4ERx in patients with non-small cell lung cancer and prostate cancer. These studies are part of Isis' broad Phase 2 development program designed to evaluate ISIS-EIF4ERx in multiple types of cancer. ISIS-EIF4ERx targets eukaryotic initiation factor-4E (eIF-4E), a traditionally "undruggable" target that is thought to promote tumor growth and metastasis in many cancers.
"It appears that children with autism develop normally for six months, and then begin developing atypically," says Rutherford. "As typical children begin to accelerate in social development, the child with autism makes only minor gains."
Research from The Shiley Center for Orthopaedic Research and Education at Scripps Clinic could change how patients are treated to prevent blood clots after joint replacement surgery. A study published as the lead article in the current issue of the Journal of Bone and Joint Surgery determined that after lower extremity joint replacement surgery a mobile compression device was just as effective as blood thinners in preventing deep vein thrombosis (DVT), but without negative side effects including bleeding complications.
Interfering with inflammatory signals produced by heart muscle cells might someday provide novel therapeutic strategies for atrial fibrillation, according to an international team of researchers who have published their findings in the journal Circulation.
› Verified 2 days ago
| NPI Number | 1326053349 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #04975 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1542 Wayne Ave, Dayton, OH 45410 |
| Phone Number | 937-254-2156 |
News Archive
Researchers with the National Cancer Institute (NCI) have found that the prevalence of tamoxifen use for the prevention of breast cancer among women without a personal history of breast cancer is very low.
Isis Pharmaceuticals, Inc. announced the initiation of two Phase 2 studies of ISIS-EIF4ERx in patients with non-small cell lung cancer and prostate cancer. These studies are part of Isis' broad Phase 2 development program designed to evaluate ISIS-EIF4ERx in multiple types of cancer. ISIS-EIF4ERx targets eukaryotic initiation factor-4E (eIF-4E), a traditionally "undruggable" target that is thought to promote tumor growth and metastasis in many cancers.
"It appears that children with autism develop normally for six months, and then begin developing atypically," says Rutherford. "As typical children begin to accelerate in social development, the child with autism makes only minor gains."
Research from The Shiley Center for Orthopaedic Research and Education at Scripps Clinic could change how patients are treated to prevent blood clots after joint replacement surgery. A study published as the lead article in the current issue of the Journal of Bone and Joint Surgery determined that after lower extremity joint replacement surgery a mobile compression device was just as effective as blood thinners in preventing deep vein thrombosis (DVT), but without negative side effects including bleeding complications.
Interfering with inflammatory signals produced by heart muscle cells might someday provide novel therapeutic strategies for atrial fibrillation, according to an international team of researchers who have published their findings in the journal Circulation.
› Verified 2 days ago
News Archive
Researchers with the National Cancer Institute (NCI) have found that the prevalence of tamoxifen use for the prevention of breast cancer among women without a personal history of breast cancer is very low.
Isis Pharmaceuticals, Inc. announced the initiation of two Phase 2 studies of ISIS-EIF4ERx in patients with non-small cell lung cancer and prostate cancer. These studies are part of Isis' broad Phase 2 development program designed to evaluate ISIS-EIF4ERx in multiple types of cancer. ISIS-EIF4ERx targets eukaryotic initiation factor-4E (eIF-4E), a traditionally "undruggable" target that is thought to promote tumor growth and metastasis in many cancers.
"It appears that children with autism develop normally for six months, and then begin developing atypically," says Rutherford. "As typical children begin to accelerate in social development, the child with autism makes only minor gains."
Research from The Shiley Center for Orthopaedic Research and Education at Scripps Clinic could change how patients are treated to prevent blood clots after joint replacement surgery. A study published as the lead article in the current issue of the Journal of Bone and Joint Surgery determined that after lower extremity joint replacement surgery a mobile compression device was just as effective as blood thinners in preventing deep vein thrombosis (DVT), but without negative side effects including bleeding complications.
Interfering with inflammatory signals produced by heart muscle cells might someday provide novel therapeutic strategies for atrial fibrillation, according to an international team of researchers who have published their findings in the journal Circulation.
› Verified 2 days ago
Cvs Pharmacy #03465 Type: Medicare Supplier Location: 524e Stroop Rd, Dayton, Ohio 45429 Phone: (937) 294-0523 | |
Cvs Pharmacy # 03467 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1300 Wilmington Ave, Dayton, Ohio 45420 Phone: (937) 254-6223 | |
Back In Motion Type: Durable Medical Equipment & Medical Supplies Supplier Location: 925 Congress Park Dr, Dayton, Ohio 45459 Phone: (937) 439-9330 | |
Cvs Pharmacy #03447 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4901n Main St, Dayton, Ohio 45415 Phone: (937) 278-5871 | |
Cvs Pharmacy #03461 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3920 Linden Ave, Dayton, Ohio 45432 Phone: (937) 254-6165 |